References
- Dubey S, Clair J, Fu TM et al. Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. J. Acquir. Immune Defic. Syndr.45(1), 20–27 (2007).
- Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature415(6869), 331–335 (2002).
- HVTN. HIV Vaccine Trials Network Conference. Grand Hyatt Seattle, WA, USA, 7–9 November 2007.
- Cohen J. AIDS research. Did Merck’s failed HIV vaccine cause harm? Science318(5853), 1048–1049 (2007).
- Offit PA. The Cutter incident, 50 years later. N. Engl. J. Med.352(14), 1411–1412 (2005).
- Kim HW, Canchola JG, Brandt CD et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol.89(4), 422–434 (1969).
- Barouch DH, Nabel GJ. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum. Gene Ther.16(2), 149–156 (2005).
- Abbink P, Lemckert AA, Ewald BA et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol.81(9), 4654–4663 (2007).
- Tatsis N, Blejer A, Lasaro MO et al. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. Mol. Ther.15(3), 608–617 (2007).
- Robinson HL, Sharma S, Zhao J et al. Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-γ, IL-2, and TNF-α co-producing CD4 and CD8 T Cells. AIDS Res. Hum. Retroviruses23(12), 1555–1562 (2007).
- Hanke T, McMichael AJ, Dorrell L. Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction. J. Gen. Virol.88(Pt 1), 1–12 (2007).
- Wang S, Kennedy J, West K et al. Balanced cellular and antibody responses induced by the polyvalent DNA prime-protein boost HIV-1 vaccine formulation DP6–001 in healthy human volunteers. Vaccine DOI: 10.1016/jvaccine.2007.12.024 (2008) (Epub ahead of print).
Websites
- NIAID. Statement: immunizations are discontinued in two HIV vaccine trials (2007) www3.niaid.nih.gov/news/newsreleases/2007/step_statement.htm
- NIAID. Questions and answers HVTN 502 and HVTN 503 HIV vaccine clinical trials (2007) www3.niaid.nih.gov/news/QA/step_qa.htm
- Fauci AS. The release of new data from the HVTN 502 (STEP) HIV vaccine study (2007) www3.niaid.nih.gov/about/directors/news/step_11707.htm.
- HVTN. Questions and answers: HVTN 204 vaccine trial (2005) www.hvtn.org/faq/204/hvtn204en.pdf